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Introduction: Leishmaniasis is endemic in more than 95 countries and is the only tropical/subtropical vector-borne
disease that has been endemic in Southern Europe for decades. To the best of our knowledge, this is the first case
of cutaneous leishmaniasis by Leishmania donovani in a child and the first cluster with adult cases reported in Europe.
Case presentation: We describe a familial cluster of four cutaneous leishmaniasis cases among Greek Cypriots caused
by L. donovani in a Paphos village, in Cyprus. A 6-year-old boy (Case number 1) had a persistent lesion in the left angle
of his upper lip, a 60-year-old woman (Case number 2) presented with a 2cm-diameter glabella lesion on her forehead,
a 60-year-old man (Case number 3) developed a lesion on his moustache area and a 40-year-old woman (Case number
4) had a lesion on her neck. In Case number 3 the lesion was self-cured; the other cases recovered after surgical resection
followed by liposomal amphotericin B (Case numbers 1 and 4) or thermotherapy and liposomal amphotericin B (Case
number 2).
Conclusions: This familial cluster of cutaneous leishmaniasis, due to the anthroponotic L. donovani, shows that the sand
fly species responsible for transmitting this parasite species is found in the area around the three neighbouring houses
involved. The factors favourable for the survival, spread and contact of the vector with people could be assessed in this
area for the establishment of preventative measures to safeguard public health.
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Leishmaniasis, a vector-borne disease, is caused by pro-
tozoans of the genus Leishmania and is endemic in
95 countries [1-4]. Transmission may be zoonotic or
anthroponotic, by the bite of female phlebotomine sand
flies. It includes a wide spectrum of manifestations ran-
ging from localised ulcerative lesions at the site of the
sand fly bite (localised cutaneous leishmaniasis, CL) to
the potentially fatal disseminated visceral form (visceral
leishmaniasis, VL).
In Southern Europe, until recently, two species were
identified as causing leishmaniasis in humans. One of
these species is Leishmania infantum, the most widely
circulating species, causing over 90% of the cases of
zoonotic CL and VL. The other is Leishmania tropica* Correspondence: mkoliou@spidernet.com.cy
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unless otherwise stated.causing anthroponotic CL, encountered sporadically in
Greece and in eastern Mediterranean countries. In
Cyprus, only two human cases of VL were reported
between 1935 and 2006 [5]. However, in 2006 six cases
of CL and VL were detected in humans and since then
sporadic cases of CL and VL are reported annually [6].
All cases have been associated with the anthroponotic
Leishmania donovani species.
We present the first familial cluster of CL cases due to
L. donovani, in Cyprus.
Case presentation
A child and three adults from an extended family, who
lived in neighbouring houses, were involved in a cluster
of CL detected in a small village in the district of Pa-
phos, where most cases of leishmaniasis in Cyprus since
2005 have been diagnosed.
Case number 1, a 6-year-old Greek Cypriot boy, was
referred to our hospital because of a small ulcerative
lesion next to the left angle of his lips (Figure 1). TheLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 The child’s lesion before treatment.
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ral despite several courses of oral antibiotics or local
antibiotic ointments. The child never complained of
fever, chills, sweating or weight loss during this time. His
previous history was unremarkable.
On examination he had a shallow ulcer right next to
the left angle of his lips with a diameter of approxi-
mately 1cm. There were no enlarged lymph nodes and
no hepatosplenomegaly. A more detailed examination of
his ear, nose and throat did not reveal any mucosal
involvement of the lesion. His full blood count and
inflammatory markers (erythrocyte sedimentation rate
and C-reactive protein) were normal. His liver and renal
function was also normal. The lesion was surgically
removed and the resected tissue was sent for histopath-
ology, culture and polymerase chain reaction (PCR) test-
ing for Leishmania parasites. Material from the lesion
was macerated, under sterile conditions, and placed in
Novy-MacNeal-Nicolle biphasic culture medium. The
culture was negative for bacteria or parasites but PCR,
using molecular screening methods: EF-PCR and k26-
PCR, a molecular assay specific for the L. donovani
complex that discriminates L. donovani/L. infantum
zymodemes [7], revealed the presence of L. donovani in
the tissue of the lesion of the patient. The histopathology
report was unremarkable other than signs of chronic
inflammation. Following surgical resection, a short course
of intravenous liposomal amphotericin B was adminis-
tered to the child at a dose of 3mg/kg/day for 7 days.
The child had no side effects and no significant scar
remained. The child was followed up for a period of
18 months with no relapse.
Case number 2, a 60-year-old Greek Cypriot woman
(the child’s godmother who lives next door) developed a
2cm diameter erythematous papule on her glabella, sim-
ultaneously to this child’s illness. Culture and PCR of
lesion material (as described above) were positive for L.
donovani [7] and subsequent typing of the isolated
parasites, using multilocus enzyme electrophoresis [8],
provided the infraspecific position of the parasite aspertaining to MON-37 zymodeme [6,9]. She was treated
at the Dermatology clinic of the University Hospital of
Crete, Greece. She was given liposomal amphotericin B
and local thermotherapy and completely recovered with
a very faint scar at the site of the lesion. No recurrence
was observed until today, 20 months later.
Case number 3, a 60-year-old Greek Cypriot man (the
child’s godfather and husband of Case number 2) had
developed a typical CL ulcer on his face, on the right,
above the moustache area. He refused to visit the doctor
and the lesion persisted for more than 1 year; it self-
resolved leaving a small scar. No material was available
for testing.
Case number 4, a 40-year-old Greek Cypriot woman
(the child’s aunt) who resided in a house next to the
child’s, had developed a lesion in her neck area approxi-
mately 1 year earlier. She had already been treated, with
surgical removal of the lesion followed by liposomal
amphotericin B and at the time of the study the scar was
evident. The doctor who had treated her described the
ulcer on her neck as a typical CL lesion.
Discussion
Clustering of cases of CL or VL caused by anthroponotic
species, such as L. donovani, especially within house-
holds, have been reported in large population studies in
endemic countries [3,4,10]. We present a cluster of four
cases of CL caused by L. donovani including a 6-year-old
boy in Cyprus. Human cases of this anthroponotic spe-
cies were detected for the first time in Europe in 2006
when the first six cases were diagnosed in the Republic
of Cyprus [6]. To the best of our knowledge, this is the
first case of CL by L. donovani in a child and the first
cluster with adult cases of CL by L. donovani reported in
Europe.
In Cyprus, there is a paradox with respect to Leishmania
epidemiology since two different, parallel, transmission
cycles appear to be involved. In the first transmission
cycle, L. infantum causes canine leishmaniasis, with 11.9%
overall seroprevalence in dogs. Although dog seropositiv-
ity for L. infantum reached 33.3% in some areas, no hu-
man VL or CL cases among Greek Cypriots have been
detected [9]. The second transmission cycle is anthropo-
notic and all known cases of CL or VL are caused by L.
donovani [6,11]. Many possible explanations have been
proposed in order to explain the origin of L. donovani in
Cyprus. Recent studies, by multilocus microsatellite
typing, showed that the L. donovani MON-37, isolated
from human cases in Cyprus, bear substantial genetic
differences to L. donovani MON-37 isolates from
India, Israel, Sri Lanka and Kenya [12]. However, they
reveal genetic similarities to isolates from Turkey sug-
gesting that the Cypriot isolates may have originated
from that country [13].
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demiological information, PCR and culture of infected
tissue, or finding the intracellular parasite in biopsy ma-
terial from the periphery of the lesion. It is not always
possible to culture the parasite (gold standard method)
since other microorganisms from the wound may infect
the culture material and stop Leishmania growth.
Treatment for CL depends on the Leishmania species
involved [14] and the means available to the hospital.
Not all patients require treatment since lesions may heal
spontaneously, after approximately 1 year, leaving a skin
scar [15]. Leishmania lesions appear to respond well to
local treatment using cryotherapy, thermotherapy or sur-
gical removal, in combination with chemical treatment;
mainly meglumine antimoniate or amphotericin B but
pentamidine isethionate, paromomycin, and antifungals
are also used [15]. Antimonials have a high incidence of
reversible adverse effects and since Leishmania drug re-
sistance to meglumine antimoniate has been reported in
some areas [16,17] it should be used with caution. Liposo-
mal amphotericin B has proved effective in cases of leish-
maniasis caused by a wide range of Leishmania species. In
particular, it has proved effective for the treatment of
paediatric VL caused by L. infantum in the Mediterranean
region [18], and L. donovani in India [19].
The child, Case number 1, was managed successfully
with surgical resection of the affected area and a short
course of liposomal amphotericin B. Our decision to use
the above treatment was supported by our previous ex-
perience of successfully treating a case of VL due to L.
donovani MON-37 in an infant originating from a
neighbouring village [6,9,11].
Treatment of CL is important because it limits skin
scarring but it also reduces the risk of metastatic infection.
For anthroponotic species, like L. donovani and L. tropica,
treatment is very important in order to stop transmission
from person to person through the reservoir.
Conclusions
It appears that most of the CL and VL cases in Cyprus
are found in a few villages in the district of Paphos. De-
tection of areas with clusters of cases may help in the
study of the conditions favouring the epidemiology of
the disease so that intervention measures could be tar-
geted in high-risk areas. In our study, all four patients
lived in three neighbouring houses, suggesting that
transmission of the parasite occurred inside or in close
proximity to these houses. The area in question is cur-
rently under investigation regarding the seasonal distri-
bution of the sand fly fauna (the vector of the disease) in
relation to the characteristics of the microenvironment
which favour their survival, spread and contact with
people. Lessons from this familial cluster and its envir-
onmental risk-factor assessment may prove beneficial tosafeguard public health and implement successful pre-
ventive and public health measures that could also be
applied in other areas and countries.
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